Trial intelligence / Profile preview

Frovatriptan versus zolmitriptan patient preference study in migraine

2006-005764-81Phase 4Completed

Sponsor
Istituto Lusofarmaco
Start
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of frovatriptan and zolmitriptan in migraine, migraine with aura and migraine without aura (2 arms), sponsored by Istituto Lusofarmaco. Primary endpoint: Patient preference for treatment medication. Started Apr 2007; status: completed.

02

Drugs

frovatriptanzolmitriptan
03

Conditions

migrainemigraine with auramigraine without aura

Beyond the preview

Go deeper on 2006-005764-81.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005764-81.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call